Works matching IS 0893133X AND DT 2008 AND VI 33 AND IP 8


Results: 28
    1
    2
    3

    In Vitro and In Vivo Characterization of the Non-peptide NK<sub>3</sub> Receptor Antagonist SB-223412 (Talnetant): Potential Therapeutic Utility in the Treatment of Schizophrenia.

    Published in:
    Neuropsychopharmacology, 2008, v. 33, n. 8, p. 1642, doi. 10.1038/sj.npp.1301549
    By:
    • Dawson, Lee A.;
    • Cato, Katherine J.;
    • Scott, Claire;
    • Watson, Jeannette M.;
    • Wood, Martyn D.;
    • Foxton, Richard;
    • de la Flor, Raúl;
    • Jones, Gareth A.;
    • Kew, James N. C.;
    • Cluderay, Jane E.;
    • Southam, Eric;
    • Murkitt, Graham S.;
    • Gartlon, Jane;
    • Pemberton, Darrel J.;
    • Jones, Declan N. C.;
    • Davies, Ceri H.;
    • Hagan, Jim
    Publication type:
    Article
    4
    5
    6
    7
    8
    9
    10
    11
    12
    13
    14
    15
    16
    17
    18
    19
    20
    21
    22
    23
    24
    25
    26
    27
    28

    AMPA Receptor Potentiation can Prevent Ethanol-Induced Intoxication.

    Published in:
    Neuropsychopharmacology, 2008, v. 33, n. 8, p. 1713, doi. 10.1038/sj.npp.1301562
    By:
    • Jones, Nicholas;
    • Messenger, Marcus J.;
    • O'Neill, Michael J.;
    • Oldershaw, Anna;
    • Gilmour, Gary;
    • Simmons, Rosa M. A.;
    • Iyengar, Smriti;
    • Libri, Vincenzo;
    • Tricklebank, Mark;
    • Williams, Steve C. R.
    Publication type:
    Article